Format
Items per page
Sort by

Send to:

Choose Destination

Results: 13

1.

Examining the Relationship between Choice, Therapeutic Alliance and Outcomes in Mental Health Services.

Stanhope V, Barrenger SL, Salzer MS, Marcus SC.

J Pers Med. 2013 Aug 20;3(3):191-202. doi: 10.3390/jpm3030191.

PMID:
25562652
[PubMed]
Free PMC Article
2.

Tardive dyskinesia in patients treated with atypical antipsychotics: case series and brief review of etiologic and treatment considerations.

Kim J, Macmaster E, Schwartz TL.

Drugs Context. 2014 Apr 9;3:212259. doi: 10.7573/dic.212259. eCollection 2014.

PMID:
24744806
[PubMed]
Free PMC Article
3.

Clinical utility of orally disintegrating olanzapine in Chinese patients with schizophrenia: a review of effectiveness, patient preference, adherence, and other properties.

Zhao J, Ou J, Xue H, Liu L, Montgomery W, Treuer T.

Neuropsychiatr Dis Treat. 2014 Feb 19;10:355-9. doi: 10.2147/NDT.S39055. eCollection 2014. Review.

PMID:
24600225
[PubMed]
Free PMC Article
4.

Pharmacologic treatment of first-episode schizophrenia: a review of the literature.

Thomas SP, Nandhra HS, Singh SP.

Prim Care Companion CNS Disord. 2012;14(1). pii: PCC.11r01198. doi: 10.4088/PCC.11r01198. Epub 2012 Jan 5.

PMID:
22690369
[PubMed]
Free PMC Article
5.

Orally disintegrating olanzapine review: effectiveness, patient preference, adherence, and other properties.

Montgomery W, Treuer T, Karagianis J, Ascher-Svanum H, Harrison G.

Patient Prefer Adherence. 2012;6:109-25. doi: 10.2147/PPA.S27344. Epub 2012 Feb 1.

PMID:
22346347
[PubMed]
Free PMC Article
6.

Treatment discontinuation and clinical outcomes in the 1-year naturalistic treatment of patients with schizophrenia at risk of treatment nonadherence.

Kelin K, Lambert T Jr, Brnabic AJ, Newton R, Ye W, Escamilla RI, Chen KP, Don L, Montgomery W, Karagianis J, Ascher-Svanum H.

Patient Prefer Adherence. 2011;5:213-22. doi: 10.2147/PPA.S16800. Epub 2011 May 9.

PMID:
21660103
[PubMed]
Free PMC Article
7.

Predictors of initiation and engagement in substance abuse treatment among individuals with co-occurring serious mental illness and substance use disorders.

Brown CH, Bennett ME, Li L, Bellack AS.

Addict Behav. 2011 May;36(5):439-47. doi: 10.1016/j.addbeh.2010.12.001. Epub 2010 Dec 10.

PMID:
21196081
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

A New Psychosocial Tool for Gaining Patient Understanding and Acceptance of Long-acting Injectable Antipsychotic Therapy.

Lasser RA, Schooler NR, Kujawa M, Docherty J, Weiden P.

Psychiatry (Edgmont). 2009 Apr;6(4):22-7.

PMID:
19724728
[PubMed]
Free PMC Article
9.

Psychoeducation in schizophrenia--results of a survey of all psychiatric institutions in Germany, Austria, and Switzerland.

Rummel-Kluge C, Pitschel-Walz G, Bäuml J, Kissling W.

Schizophr Bull. 2006 Oct;32(4):765-75. Epub 2006 Jul 14.

PMID:
16844723
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

A review of pharmacologic strategies for switching to atypical antipsychotics.

Masand PS.

Prim Care Companion J Clin Psychiatry. 2005;7(3):121-9.

PMID:
16027767
[PubMed]
Free PMC Article
11.

Atypical Antipsychotic Use in the Treatment of Psychosis in Primary Care.

Leo RJ, Regno PD.

Prim Care Companion J Clin Psychiatry. 2000 Dec;2(6):194-204.

PMID:
15014629
[PubMed - as supplied by publisher]
Free PMC Article
12.

Compliance therapy in psychotic patients: randomised controlled trial.

Kemp R, Hayward P, Applewhaite G, Everitt B, David A.

BMJ. 1996 Feb 10;312(7027):345-9.

PMID:
8611831
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Will the new antipsychotics improve the treatment of schizophrenia?

Hale T.

BMJ. 1993 Sep 25;307(6907):749-50. No abstract available.

PMID:
8106051
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk